Gene therapy for pancreatic cancer.
It has been approximately 7 years since the introduction of gene therapy. Since conventional procedures such as surgery, chemotherapy, and radiotherapy have had limited therapeutic value for cancer patients, the evolution of gene therapy seems a promising alternative to many researchers and clinicians. Indeed, about half of all gene therapy treatments are administered to patients with cancer. However, there are relatively few studies of using gene therapy with pancreatic cancer. We will review the general concept of gene therapy for cancer and its accomplishments to date.
Department of Surgery II, Nagoya University School of Medicine, Japan.
S
S
Takeda
A
A
Nakao
K
K
Miyoshi
H
H
Takagi
D019450:Genes, MDR / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D005822:Genetic Vectors; D006801:Humans; D016219:Immunotherapy, Adoptive; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000628:therapy*; D016372:RNA, Antisense
D016372:RNA, Antisense